Literature DB >> 2572927

Oral limaprost for Raynaud's phenomenon.

C Murai, T Sasaki, H Osaki, A Hatakeyama, S Shibata, K Yoshinaga.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2572927     DOI: 10.1016/s0140-6736(89)91824-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy.

Authors:  M Miura; I Sasagawa; Y Kubota; Y Iijima; T Sawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 2.  Drug treatment of scleroderma.

Authors:  C Leighton
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Pharmacotherapy of Raynaud's phenomenon.

Authors:  J J Belch; M Ho
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.